| --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | BiomX | | | | | | Safe Harbor Statement 2 This presentation contains certain "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "target," "believe," "expect," "will," "may," "anticipat ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38762 BiomX Inc. (Exact Name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | Delaware | 82-3364020 | | --- | --- | | (State or other juris ...

BiomX Inc. (NYSE:PHGE) Q3 2021 Earnings Conference Call November 15, 2021 8:00 AM ET Company Participants Marina Wolfson - SVP of Finance Jonathan Solomon - CEO Sailaja Puttagunta - Chief Medical Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Michael Higgins - Ladenburg Thalmann Kristen Kluska - Cantor Fitzgerald Keay Nakae - Chardan Capital Michael Higgins - Ladenburg Thalmann Operator Greetings and welcome to BiomX Inc Third Quarter 2021 Financial Results. At this time, all participa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 For the transition period from to Commission file number: 001-38762 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 BiomX Inc. | Delaware | 82-3364020 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organizat ...

| --- | --- | --- | --- | --- | --- | |----------------------|-------|-------|---------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | BiomX | | | | | | | Company Introduction | | | ADVANCING MEDICINE. | | | | | | | PRECISELY. | | | Safe Harbor Statement 2 This presentation contains certain "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-lo ...

BiomX Inc. (NYSE:PHGE) Q2 2021 Results Conference Call August 16, 2021 8:00 AM ET Company Participants Marina Wolfson - Senior Vice President of Finance and Operations. Jonathan Solomon - Chief Executive Officer and Board Member Dr. Sailaja Puttagunta - Chief Medical Officer Assaf Oron - Chief Business Officer Conference Call Participants Michael Higgins - Ladenburg Thalmann Kristen Kluska - Cantor Fitzgerald Keay Nakae - Chardan Capital Markets Operator Greetings and welcome to BiomX Second Quarter 2021 Fi ...

BiomX Inc. (NYSE:PHGE) Q1 2021 Results Conference Call May 24, 2021 8:00 AM ET Company Participants Marina Wolfson - Senior Vice President of Finance and Operations. Jonathan Solomon - Chief Executive Officer and Board Member Dr. Sailaja Puttagunta - Chief Medical Officer Assaf Oron - Chief Business Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Keay Nakae - Chardan Capital Markets Matt Keller - H.C. Wainwright Michael Higgins - Ladenburg Thalmann Operator Good morning and welcome t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission file number: 0001-38762 BIOMX INC. (Exact name of registrant as specified in its charter) | Delaware | 82-3364020 | | --- | --- | | (State or othe ...

BiomX Inc. (NYSE:PHGE) Q4 2020 Results Earnings Conference Call March 31, 2021 8:00 AM ET Company Participants Marina Wolfson - Senior Vice President for Finance and Operations. Jonathan Solomon - Chief Executive Officer and Board Member Assaf Oron - Chief Business Officer Sailaja Puttagunta - Chief Medical Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Keay Nakae - Chardan Capital Markets Joe Pantginis - H.C. Wainwright Operator Greetings. Welcome to BiomX Fourth Quarter and Full Y ...